Disease modification in osteoarthritis: are drugs the answer?
Dieppe
Paul
P
D000818:Animals; D000880:Anthraquinones / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002358:Cartilage, Articular / Q000187:drug effects / Q000201:enzymology / Q000473:pathology; D017364:Collagenases / Q000378:metabolism; D004195:Disease Models, Animal; D004318:Doxycycline / Q000627:therapeutic use*; D004792:Enzyme Precursors / Q000378:metabolism; D006801:Humans; D010003:Osteoarthritis / Q000188:drug therapy* / Q000201:enzymology / Q000473:pathology
D000880:Anthraquinones; D000900:Anti-Bacterial Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D018501:Antirheumatic Agents; D004792:Enzyme Precursors; C025292:diacerein; D017364:Collagenases; C022440:procollagenase; D004318:Doxycycline